Major Generic Pharmaceutical Company Admits to Antitrust Crimes

Sandoz Inc., a generic pharmaceutical company headquartered in New Jersey, was charged for conspiring to allocate customers, rig bids, and fix prices for generic drugs, the Department of Justice announced.  A four-count felony charge was filed today in the United States District Court for the Eastern District of Pennsylvania in Philadelphia, charging Sandoz with participating in four criminal antitrust conspiracies, each with a competing manufacturer of generic drugs and various individuals.  This represents the third pharmaceutical company to admit to criminal antitrust charges in the Antitrust Division’s ongoing investigation.  The charged conspiracies took place between 2013 and 2015.